UPDATED
June 23
New Users Please Click to Register
Renew or Upgrade your Existing  Account
UPDATE EMAIL
CHECK STATUS
CHECK PASSWORD

DISCLOSURE
BOOKMARK-HDCN
VBOOTHS
ABOUT OUR SITE
SYMPOSIA
FREE ZONE INDEX
ABSTRACTS
BY DATE
BY TOPIC
SEARCH HDCN
JOURNALS
SOCIETIES, LINKS
CLINICAL TRIALS
HYPERTENSION
DIALYSIS-CRF
CLIN NEPHROL
FREE ZONE
KEY ZONE
SEARCH

VBOOTHS :  Google :  PubMed  :   Scholar  :   K/DOQI :  UpToDate :  MDRD GFR
Slides/audio/handouts:    RRI-2009(s/a/h)  :  ASN-2008(a)  :  NANT-2008(a)  :  ADC-2008(a)  :  Network9,10-2008(s/a/h)  :  RPA-2008(s/a/h)  :  ASDIN-2008(s/a/h)  :  RRI-2008(s/a/h)  :  ASN-2007(a)  :  ADC-2007(a)  :  RPA-2007(s/a)  :  RRI-2007(s/a/h)  : 
TalksbyDate   Search HDCN:  FreeTalks   (key):   Articles :  Abstracts :  Audiofiles :  SlideTalks :  LegacyTalks  

Feehally  

Hogg  

  IgA Nephropathy: Time to Change Our Approach? Flash slide/audio
(ASN Renal Week Clinical Nephrology Conference Extract, November, 2008)
Feehally: All cases of IgAN truly are not the same. How can we better understand disease variation? Predict prognosis? Choose the best treatment strategy? How does age affect presentation? Geographic location? What do we know about crescentic IGAN? Secondary disease? What are the data regarding recurrence of IgAN in transplants? Is microscopic hematuria only a benign presentation? Do we really know that IGAN is a single disease? How do we choose the best treatment for each of the variant clinical presentations? Does tonsillectomy work? What is the role for fish oil, BP control, renin-angiotensin blockade, and corticosteroids and immunosuppression? Hogg: What is the role for steroids and immunosuppression in IgAN? When should these drugs be used initially? When as a second line of treatment? Are all IS drugs equal in potency and/or effect? Does response to an IS drug depend on dosage, duration, or method of administration? To what extent are these questions answerable with the present data?
(more...)


Hypertension, Cardiovascular
CRP activates white blood cells
Red yeast rice when statins tough to take
Anti-HTN meds during pregnancy
Triple anti-HTN therapy
Prolactin and atherosclerosis
Ramipril at bedtime
Low fitness levels and visceral adiposity
Adiposity and BP risk
Aliskiren vs. ACE inhibitors (review)
CKD, ESRD
Hypotension unawareness
Calcium supplementation no good for weight loss
Trace elements in ESRD
PTH and CV risk in the community
Pill burden bad
Phosphate and CV risk in the community
Incenter 3/week nocturnal ok
Serum alk phos and CAC
Another intensified dialysis RCT for ICU is negative
Switching from graft to fistula good
Clinical Nephrology
Nephrotic syndrome with NPHS1 and 2
Rituximab for membranous GN
Amiloride for lithium toxicity
High cystatin marks metabolic abnormalities
Rituximab and MMF for relapsing lupus GN






    Hit reload / refresh
Login stopped working? Bouncing email logins suspended.
Slide/audio problem when lectures played with legacy options using Windows Media or Real Player.
HDCN_RSS  Click on RSS for details of each news story.
Updated: July 03, 2009 (Jul03)
Jul03 In the kidney organ trade, sellers often have regrets and remorse over their decision.
Jul03 Dialysis patient celebrates 100th birthday
Jul03 Nephros gets FDA 510K approval for using its dual filter to clarify water for dialysis machines.
Jul03 Kidney disease education to be part of CMS 2010 proposal for coverage.
Jul03 CMS releases proposed changes to physician payment schedule for 2010.
Jul03 Low PSA 5 years after brachytherapy for prostate cancer and you're probably home free.
Jul03 Dialysis patient blogs about end-of-life issues
Jul02 Newspaper comic strip to target diabetes awareness among Hispanics.
Jul02 JBS Swift Co. beef associated with hospitalization of 12 persons in Washington D.C.
Jul02 Fresenius opens specialty pharmacy for renal patients in Nashville.
Jul02 Fresenius inks agreement with ART to market Citrasate dialysate.
Jul02 U.S. obesity problem intensifies.
Jul02 FDA reviewing safety data for Lantus (insulin glargine) in view of reports of increased cancer risk.
Jul02 CME proposes changes to physician payment in 2010, including dropping consultation codes.
Jul02 NEJM: Phospholipase A2 receptor is a target antigen in 70% of patients with idiopathic membranous nephropathy.
Jul02 Rebound hyperacidity, reflux symptoms in normals after stopping proton pump inhibitors
Jul02 Enalapril or losartan markedly slow progression of eye damage in type 1 diabetics.
Jul02 JBS Swift beef products recalled in Western states due to toxigenic E. coli.
Jul01 Institute of Medicine Comparative Effectiveness Report lists 100 priorities, including evaluation of different forms of dialysis.
Jul01 Nephrology consults via telemedicine in California hospital
General Advances Emphasis
archive
Phosphate levels and cardiovascular disease in the general population
Foley reviews the recent evidence from community based trials suggesting increased cardiovascular risk being associated with serum phosphate levels in the normal range in persons with either normal or mildly reduced renal function; in the June issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

Recent developments in kidney transplantation -- a critical assessment
Womer and Kaplan discuss new developments on defining graft loss, minimizing immunosuppression, and optimizing graft allocation; in the June issue of the Am J Transplant. (more...)

Prediction, progression, and outcomes of chronic kidney disease in older adults
Sharon Anderson and colleagues summarize a recent workshop dealing with mechanisms of CKD in the elderly, how CKD should be classified and staged, and goals for clinical management; in the June 2009 issue of the J Am Soc Nephrol (JASN) (more...)

Stent placement in hemodialysis access: historical lessons, the state of the art and future directions
Yevzlin and Allon discuss when a stent may be useful, and when it is contraindicated; in the May issue of the Clinical J Am Soc Nephrol (CJASN) (more...)

Sympathetic activation in chronic renal failure
Schlaich et al discuss why sympathetic tone is elevated in CKD, how this affects increased cardiovascular risk, and what we can do about it; in the May 2009 issue of the J Am Soc Nephrol (JASN) (more...)

Hemodialysis vascular access monitoring: Current concepts
Should we monitor or not? Initial enthusiasm was replaced by doubt after results of randomized studies were published. Allon and Robbin review the state of knowledge as of 2009; in the April 2009 issue of the Hemodial Int (more...)

Drug dosing during continuous renal replacement therapy
Churchwell and Mueller review this very useful clinical topic, including discussion of more modern higher efficiency CRRT treatments. in the Mar/April issue of Seminars in Dialysis. (more...)

450+
  SUMMARIES of Recent Slide/Audio Symposia in reverse chronological order

IgA Nephropathy: Time to Change Our Approach? (Feehally and Hogg)
Advances in CKD 2009 (various speakers)
CKD Care and Your Practice Culture: Improve Your Performance! (Maddux, Molony, Kliger, Blaser, et al)
The Sexual Life Cycle of Women with CKD (Yao, Hou, Kurella-Tamura)
Resistant Hypertension: A Challenge for the Nephrologist (Campese and Steigerwalt)
New Frontiers in Phosphorus Homeostasis in CKD (Quarles, Wolf)
Care of the Chronic Kidney Disease Patient (Campbell, Berns, Batlle)
Managing CKD-MBD through the Disease Continuum (Thadhani, Kestenbaum)
Restoring Balance: New Therapeutic Approaches to Acute Decompensated Heart Failure (Goldberg, Schrier, and Gheorghiade)
The Year in Nephrology: Hypertension and Metabolic Renal Syndrome (Griffin and Beddhu)
Nephrology Roundtable: Glucose Transport and Targets for Intervention (De Zeeuw, Wright)
Acute Renal Replacement Therapy (Palevsky)
The ESA Controversy: The Role of Intravenous Iron (Ganz, Agarwal, Besarab)
Shades of Grey: Key Questions in the Future of Treatment for CKD-Related Anemia (Schmidt, Toto, Norris)
Gammopathies and the Kidney and Thrombotic Microangiopathy (Falk)
Ischemic Nephropathy: Diagnosis and Management (Textor)
Disorders of Calcium and Phosphorus Metabolism (Wolf)
FREE
Managing Anemia in Chronic Kidney Disease: The Benefits to Patients (Schira)
  Preparing for the New Medical Director Responsibilities (Network 9/10 - RPA Special Symposium)
Nephrology Quiz and Questionnaire: Fluid and Electrolyte and Glomerulonephritis Cases (Emmett and Radhakrishnan)
Controversies in Diagnosis and Treatment of Atherosclerotic Renovascular Disease (Textor and Dworkin)
FREE
What You Can Teach Your Team About Chronic Kidney Disease-Related Mineral Bone Disorder (CKD-MBD) (Schmidt and Senft)
New Insights, Treatments, and Management Strategies for ADPKD (Chapman and Calvet)
FREE
Stabilizing Hemoglobin Levels: What's New in IV Iron and Anemia Management? (Fishbane, VanBuskirk, Larson)
Novel Therapeutics for Fluid and Electrolyte Disorders (Verbalis and Palmer)
DILEMMAS IN THE TREATMENT OF GLOMERULAR DISEASE:
Treatment of Frequently Relapsing/Steroid Dependent Minimal Change Disease (Hogg);
Evaluation and Treatment Approach to Steroid-Resistant Primary FSGS in Adults (Meyrier).
Congestive Heart Failure: A Nephrologist's Disease? (Murray)
AKI Therapeutics: From Bench to Commercialisation (Molitoris)
FREE
New Perspectives on the Progression of Coronary Artery Calcification and Patient Outcomes in Chronic Kidney Disease (Qunibi, Szczech)
Renal Disease and the Metabolic Syndrome (Muntner and Fried)
Nephrolithiasis (Worcester and Lieske)
The Genetics of FSGS (Hildebrandt and Kaskel)
Primary Care Issues in Nephrology: Peripheral Vascular Disease: Assessments and Approaches to Care (Froehlich); Rheumatology for Nephrologists (Kay).
Achieving Control: Optimizing the Management of CKD-Anemia (Nissenson, Fishbane, Germain, and Provenzano)
Mycophenolate in Lupus and Non-Glomerular Renal Diseases (Shaw and Appel)
  ASDIN Annual Meeting 2008
  RPA Annual Meeting 2008
  Advances in CKD 2008 (RRI 10th Annual International Dialysis Symposium
Management of Hyperphosphatemia in Patients with ESRD: A New Direction for Treatment in 2008 (Qunibi and Nolan)
Aldosterone: New Insights in Kidney Health and Disease (Calhoun and Rosenberg)
Pre-ESRD and Mineral Metabolism (Martin and Moe)
New Insights into Common Problems After Kidney Transplantation (Kasiske and Weisinger)
Challenges and Opportunities in the Treatment of Hyperuricemia and Gout (Terkeltaub, Rich, Feig)
New Treatments for Diabetes Mellitus: Implications for Clinicians (Nelson and Bakris)
The Aging Kidney (Fliser and Aronoff)
Phosphate Binders in CKD: An Update on Treatment Outcomes and Future Directions (London, Langman, Ketteler)
Challenges in Volume Management. Optimizing Care in Patients with Heart Failure and Renal Dysfunction (Burnett, Fowler, Gheorghiade)
Cardiovascular Disease in End Stage Renal Disease Patients (Henrich)
Contrast Media and CKD: What You Should Know About Contrast-Induced Nephropathy and Nephrogenic Systemic Fibrosis (Persson, Knopp, Perazella)
New Developments in Anemia Management in Chronic Kidney Disease (Roy, Besarab, Amerling, Berns)
The Cystic Diseases (Bennett)
Navigating the Erythropoietin Stimulating Agent Landscape in CKD-Related Anemia (Berns, Provenzano, Szczech)
Critical Care Nephrology (Murray)
FREE
Chronic Kidney Disease - Mineral Bone Disorder (Arruda, Snavely)
Electrolyte/Acid-Base Emergencies in the ICU (Palmer)
Nocturnal and Frequent Dialysis: Are These the Preferred Therapies for Patients with Cardiovascular Disease?
FREE
Updating Practices in an Evolving IV Iron and Anemia Environment: Practical Solutions. A New Anemia Treatment Paradigm in Favor of the Patient (Easom, Juergensen, Amerling)
Sudden Death in Hemodialysis Patients: Epidemiology
Diabetes and Non-insulin Management in CKD
Obesity and Outcomes in Dialysis Patients
Is Obesity a Risk Factor for the Development And Progression of Chronic Kidney Disease?
FREE
Standards: The Basis of Care to Manage the Patient with Complications of Chronic Kidney Disease Leading to Cardiovascular Disease (Burrows-Hudson, Headley, Campoy)
FREE
Achieving and Maintaining a Phosphate Balance in the Patient With CKD (Mathers)
Cocaine and Chronic Kidney Injury
Proton Pump Inhibitors and the Kidney: Critical Review
Characteristics of the Long-Term Peritoneal Dialysis Patient
Prospects and Challenges for a Staphylococcal Vaccine
Alternatives to Vancomycin in the Treatment of Gram-Positive Cocci
Overview of Catheter Lock Solutions
Are ACE inhibitors and ARBs Essential to Renoprotection? Debate.
Early Anemia Management: Incorporating New Evidence Into Appropriate Treatment Strategies for Chronic Kidney Disease
3rd Annual Scientific Meeting of the ASDIN. April, 2007.
Improving Efficiency in the Nephrologist's Office. RPA Annual Meeting (2007)
RRI Ninth International Conference on Dialysis, January, 2007. Part Four
Bone and Mineral Metabolism in CKD: Medical Crossfire
RRI Ninth International Conference on Dialysis, January, 2007. Part Three
Fluid Dysregulation: Disturbances and Management
RRI Ninth International Conference on Dialysis, January, 2007. Part Two
Inflammation in CKD: Biomarkers, Morbidity and Therapy
Managing CMV Infections in Transplantation
RRI Ninth International Conference on Dialysis, January, 2007. Part One
Disorders of Sodium Metabolism: Case Presentations
The CKD that Follows Renal Transplantation: How to Best Manage these Patients?
Transplant Biopsy
The New KDOQI Guidelines for Anemia; Debate: Should an Upper Hgb Limit be Set and What Should it Be?
Calcimimetics: Monotherapy for Secondary Hyperparathyroidism?
Lupus Nephritis: Defining and Treating Renal Flares
Secondary Hypertension, including Chronic Kidney Disease
New, Tri-Partite Approach to Anemia
Magnesium Balance: Hypomagnesemia and Hypermagnesemia
Pathogenesis and Management of Cardiovascular Disease (CVD) in Chronic Kidney Disease
Transplantation: Medical and Immunosuppressive Management
  Using Technology to Improve the Quality of Care (target audience: technicians)
more...









 
Site Description:
Hypertension, Dialysis, and Clinical Nephrology provides up-to-date, selected information on renal disorders and their treatment (hemodialysis, peritoneal dialysis), and about hypertension, dialysis, and clinical nephrology topics.
Hypertension, Dialysis, and Clinical Nephrology is a place for physicians and nurses who treat patients with kidney or renal disease. Here physicians and nurses can find answers to frequently asked hypertension, dialysis, and nephrology questions (FAQ), pointers to recent review articles, and summaries of hot new hypertension, dialysis, and nephrology papers, abstracts, and meeting presentations. Also, information about medical products, devices, services, and drugs pertaining to hypertension, dialysis, and clinical nephrology are provided, as is a list of links to relevant hypertension / dialysis / transplantation organizations, medical provider networks, and databases. Much of the information presented is collected from a distinguished editorial board composed of specialists in the field of kidney or renal disease.

Warning-Disclaimer:
The information at this server is provided with the understanding that the publisher, authors, and advisors are not rendering medical or professional services. Medicine is a rapidly changing area, and efforts have been made to provide information that is medically correct at the time of publication. However, there may be mistakes, both typographical and in content. The material provided should be used only as a general guide and not the ultimate source of information. The material should not be used to form the basis of personal or professional decisions. The authors, advisors, and publisher shall have neither liability not responsibility to any person or entity with respect to any loss or damage alleged to be caused directly or indirectly by the information presented in this journal/server.

Copyright statement:
Copyright - 1995 - 2008 by Medtext, Inc. All rights reserved. No part of the material on this journal/server may be reproduced in any form or by any electronic or mechanical means, including information storage and retrieval systems, without permission in writing from the publisher, except by a reviewer who may quote brief passages in a review.

Published by Medtext, Inc., Burr Ridge, IL, 630-325-3276
E-mail to: editor (at sign) hdcn.com

96 97 98 99